Search

Copyright of Archives of Veterinary Science is the property of Archives of Veterinary Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Progressive Retinal Atrophy (PRA) is the term used to generalize a variety of conditions that cause inherited retinal dystrophy or retinal degeneration in animals. In cats, hereditary eye diseases such as PRA are uncommon compared to their frequencies in dogs. The case to be reported is a mongrel cat, 11, who showed clinical signs very similar to Progressive Retinal Atrophy. The patient had also past history of intense treatment with antibiotics in the first year of life. The Toxic retinopathy induced by the use indiscriminate of enrofloxacin in cats is one differential diagnoses for PRA. The reported case becomes atypical because the Retina Atrophy Progressive is a disease that, when it affects cats, a fact rarer than in dogs, usually affects the Abssínio breed, Somali, Siamese and Persian. In this case, the patient is a mongrel cat. Although the patient's history isn't compatible with toxic retinopathy, this possibility isn't ruled out completely, even if the drug was given 10 years ago, because the final stages of the PRA the retinal changes are similar to intoxication for enrofloxacin . So, for the final confirmation of the diagnosis would be necessary to carry out a genetic test for identification of the allele responsible for the disease. [ABSTRACT FROM AUTHOR]

Objective: To assess the efficacy of 0.1% oclacitinib as a single agent, and in combination with tacrolimus 0.01%, for the control of ophthalmic signs of keratoconjunctivitis sicca (KCS) in dogs., Animals Studied: Thirty-two dogs (57 eyes) diagnosed with idiopathic KCS were included. Inclusion criteria were Schirmer Tear Test 1 (STT-1) values <15 mm/min and concurrent clinical signs such as ocular hyperemia and discharge., Procedures: The animals were submitted to a randomized, open-label, 5-week study and divided into 3 treatment groups treated with the following ophthalmic solutions: (a) 0.1% oclacitinib, (b) 0.1% oclacitinib +0.01% tacrolimus, and (c) 0.01% tacrolimus. Eye drops were instilled twice daily (12-hour intervals). At each follow-up examination, STT-1, clinical signs, and potential drug side effects were assessed., Results: Oclacitinib did not significantly improve STT-1 values or clinical scores. Tacrolimus alone and in combination with oclacitinib increased mean STT-1 values by 11.84 ± 5.2 and 12.46 ± 5.3 mm/min, respectively (P = 0.0001). Clinical scores of ocular discharge and hyperemia also improved significantly in both groups receiving treatment with tacrolimus (P < 0.05). However, addition of oclacitinib to tacrolimus provided no additional improvement over tacrolimus alone., Conclusions: Topical 0.1% oclacitinib twice daily is not effective in controlling the ocular signs of KCS in dogs. 0.01% tacrolimus increased STT-1 values significantly and could potentially be used as a treatment for mild-to-moderate cases of KCS. Synergism between drugs did not occur, and therefore the use of oclacitinib is not justified in cases of canine KCS., (© 2019 American College of Veterinary Ophthalmologists.)

We examined the presence of antibodies against the parasites Toxoplasma gondii, Neospora caninum, and Leishmania spp., as well the presence of DNA from Leishmania spp., in dogs from Pirassununga - SP. The seropositivity rate was compared with the animals' originating location. Three hundred seventy-three blood samples from the county's kennel and local veterinary clinics were collected and analyzed. A total of 300 samples were tested for T. gondii and N. caninum using an indirect immunofluorescence antibody test (IFAT); 45% (135/300) were positive for T. gondii and 24.3% (73/300) were positive for N. caninum. Three hundred seventy-three samples were tested for Leishmania spp. using the IFAT. Of these, 4.6% (17/373) were positive. Additionally, 145 samples were tested using a polymerase chain reaction (PCR); of these samples, 0.7% (1/145) was positive. Considering the results, we conclude that these parasites are present in the city of Pirassununga - SP and that the animals have contact with the protozoan. It is therefore necessary to create methods for disease prevention to maintain both animal and human health in regard to leishmaniasis and toxoplasmosis.